Drug profile · INN
sertaconazole nitrate
ERTACZO
sertaconazole nitrate (ERTACZO) is a cytochrome p450 51 inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — sertaconazole nitrate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
sertaconazole nitrate (ERTACZO) is a cytochrome p450 51 inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Cytochrome P450 51 inhibitor
Primary target: Lanosterol 14-alpha demethylase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sertaconazole nitrate?
sertaconazole nitrate (ERTACZO) is a cytochrome p450 51 inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for sertaconazole nitrate?
ERTACZO is a marketed brand name for sertaconazole nitrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sertaconazole nitrate?
sertaconazole nitrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.